The present invention comprises an anti-muscle-specific kinase (MuSK) B cell receptor (BCR) -specific chimeric autoantibody receptor (CAAR), a composition comprising the CAAR, a polynucleotide encoding the CAAR, and the CAAR. Includes a vector containing the encoding polynucleotide and recombinant cells containing the CAAR.